SC 13G/A | 2024-02-14 | Iroquois Capital Management, LLC | MyMD Pharmaceuticals, Inc. | 187,421 | 5.0% | EDGAR |
SC 13G | 2024-02-14 | Global X Management CO LLC | MyMD Pharmaceuticals, Inc. | 3,108,473 | 6.1% | EDGAR |
SC 13G/A | 2023-02-14 | Iroquois Capital Management, LLC | MyMD Pharmaceuticals, Inc. | 31,184 | 2.8% | EDGAR |
SC 13D | 2022-09-08 | DUFFEY SAMUEL S | MyMD Pharmaceuticals, Inc. | 2,241,812 | 5.9% | EDGAR |
SC 13G/A | 2022-02-23 | Iroquois Capital Management, LLC | MyMD Pharmaceuticals, Inc. | 260,366 | 3.7% | EDGAR |
SC 13G/A | 2022-02-11 | INTRACOASTAL CAPITAL, LLC | MyMD Pharmaceuticals, Inc. | 364,963 | 1.0% | EDGAR |
SC 13G/A | 2022-01-11 | MAINFIELD ENTERPRISES INC | MyMD Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13D | 2021-04-27 | Williams Caroline C | MyMD Pharmaceuticals, Inc. | 5,020,181 | 13.2% | EDGAR |
SC 13G/A | 2021-02-22 | Iroquois Capital Management, LLC | Akers Biosciences, Inc. | 969,998 | 10.0% | EDGAR |
SC 13G | 2021-02-18 | MAINFIELD ENTERPRISES INC | Akers Biosciences, Inc. | 1,081,081 | 5.8% | EDGAR |
SC 13G/A | 2021-01-29 | INTRACOASTAL CAPITAL, LLC | Akers Biosciences, Inc. | 1,459,458 | 7.5% | EDGAR |
SC 13G | 2020-11-20 | INTRACOASTAL CAPITAL, LLC | Akers Biosciences, Inc. | 1,459,458 | 7.5% | EDGAR |
SC 13G/A | 2020-11-19 | Iroquois Capital Management, LLC | Akers Biosciences, Inc. | 770,270 | 10.0% | EDGAR |
SC 13G | 2020-05-26 | INTRACOASTAL CAPITAL, LLC | Akers Biosciences, Inc. | 195 | 0.0% | EDGAR |
SC 13G/A | 2020-05-05 | Hudson Bay Capital Management LP | Akers Biosciences, Inc. | 1,885 | 0.0% | EDGAR |
SC 13G/A | 2020-04-20 | ALPHA CAPITAL ANSTALT | Akers Biosciences, Inc. | 200,000 | 4.2% | EDGAR |
SC 13G | 2020-04-17 | INTRACOASTAL CAPITAL, LLC | Akers Biosciences, Inc. | 195 | 0.0% | EDGAR |
SC 13G | 2020-01-09 | Hudson Bay Capital Management LP | Akers Biosciences, Inc. | 269,243 | 15.7% | EDGAR |
SC 13G | 2019-12-19 | INTRACOASTAL CAPITAL, LLC | Akers Biosciences, Inc. | 58,895 | 5.0% | EDGAR |
SC 13G | 2019-12-18 | Iroquois Capital Management, LLC | Akers Biosciences, Inc. | 88,000 | 10.0% | EDGAR |